Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

738
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
738
Positron Emission Tomography01:29

Positron Emission Tomography

8.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.0K
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

617
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
617

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling.

Cell reports. Medicine·2026
Same author

Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma.

bioRxiv : the preprint server for biology·2026
Same author

Single stereocenter inversion of a cyclic tetrapeptide enables the detoxification of lead-exposed mice.

Chemical science·2026
Same author

[<sup>64</sup>Cu]Cu-Labeled αCD11b Diabody as a Novel PET Tracer for the Detection of Immunosuppression in Glioblastoma.

ACS omega·2026
Same author

Development of an automated one-step radiolabeling procedure for a PSMA-targeted radiotherapeutic for prostate cancer.

Nuclear medicine and biology·2026
Same author

Matched pair suitability of <sup>89</sup>Zr and <sup>177</sup>Lu-labeled L804-LLP2A theranostics for targeting VLA-4 in melanoma.

Nuclear medicine and biology·2025

Related Experiment Video

Updated: Mar 21, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

2.1K

Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Jason P Holland1, Riccardo Ferdani2, Carolyn J Anderson2

  • 1Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

PET Clinics
|May 10, 2016
PubMed
Summary

Copper-64 (64Cu) offers high-quality PET imaging with a longer half-life than Fluorine-18 (18F). Its versatile chemistry makes it ideal for advanced radiopharmaceuticals requiring extended circulation times.

More Related Videos

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Published on: April 29, 2017

9.3K
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

7.0K

Related Experiment Videos

Last Updated: Mar 21, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

2.1K
Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT

Published on: April 29, 2017

9.3K
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
07:26

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

7.0K

Area of Science:

  • Nuclear medicine
  • Radiochemistry
  • Medical imaging

Background:

  • Positron emitting radionuclide (64)Cu has a 12.7-hour half-life.
  • (64)Cu enables PET imaging quality comparable to (18)F.
  • Copper's longer half-life and versatile chemistry present advantages over shorter-lived nuclides.

Purpose of the Study:

  • To discuss copper-64 radiopharmaceuticals translated to clinical use.
  • To highlight new developments in copper-based radiopharmaceuticals.
  • To explore (64)Cu as an alternative to (18)F for PET imaging.

Main Methods:

  • Review of existing literature on (64)Cu radiopharmaceuticals.
  • Discussion of clinical translation of agents like Cu-ATSM.
  • Exploration of copper's chemical properties for radiolabeling.

Main Results:

  • (64)Cu PET imaging quality is comparable to (18)F.
  • (64)Cu's longer half-life is beneficial for imaging molecules with longer circulation times.
  • Several copper radiopharmaceuticals, including Cu-ATSM, have been successfully translated to the clinic.

Conclusions:

  • Copper-64 is an attractive radionuclide for PET imaging due to its favorable decay characteristics and versatile chemistry.
  • The longer half-life of (64)Cu supports its use in developing novel radiopharmaceuticals for peptides, antibodies, and small molecules.
  • Ongoing developments in copper radiopharmaceuticals promise expanded clinical applications.